Protective role of urinary trypsin inhibitor in lung expression of proinflammatory cytokines accompanied by lethal liver injury in mice

Immunopharmacology and Immunotoxicology

Volumn 31, Issue 3, 2009, Pages 446-450

  Inoue, Ken Ichiro ^a   Takano, Hirohisa ^a,b   Sato, Hiroyuki ^c   Yanagisawa, Rie ^a   Yoshikawa, Toshikazu ^b  

^a NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c MOCHIDA PHARMACEUTICAL CO   (Japan)

Author keywords

D galactosamine; Disseminated intravascular coagulation; Lipopolysaccharide; Liver injury; Urinary trypsin inhibitor

Indexed keywords

GALACTOSAMINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; ULINASTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENOTYPE; LIVER INJURY; LIVER PROTECTION; MALE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

ANIMALS; CYTOKINES; DRUG-INDUCED LIVER INJURY; GALACTOSAMINE; GENE EXPRESSION REGULATION; GLYCOPROTEINS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; LUNG; MALE; MICE; MICE, KNOCKOUT;

MUS;

EID: 70350689765     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.1080/08923970902769646     Document Type: Article

References (27)

1. Sato, H., Kajikawa, S., Kuroda, S., Horisawa, Y., Nakamura, N., Kaga, N., Kakinuma, C., Kato, K., Morishita, H., Niwa, H., Miyazaki, J. Impaired fertility in female mice lacking urinary trypsin inhibitor. Biochem. Biophys. Res. Commun. 2001, 281,1154-1160.
2. Sumi, H., Takada, Y., Takada, A. Studies on human urinary trypsin inhibitor. 1. Its modification on treatment of urine with acid. Thromb. Res. 1977, 11,747-754.
3. Wachter, E., Hochstrasser, K. [Kunitz-type proteinase inhibitors derived by limited proteolysis of the inter-alpha-trypsin inhibitor, IV. The amino acid sequence of the human urinary trypsin inhibitor isolated by affinity chromatography]. Hoppe Seylers Z Physiol. Chem. 1981, 362,1351-1355.
4. Masuda, T., Sato, K., Noda, C., Ikeda, K.M., Matsunaga, A., Ogura, M. N., Shimizu, K., Nagasawa, H., Matsuyama, N., Izumi, T. Protective effect of urinary trypsin inhibitor on myocardial mitochondria during hemorrhagic shock and reperfusion. Crit. Care. Med. 2003, 31,1987-1992.
5. Zaitsu, M., Hamasaki, Y., Tashiro, K., Matsuo, M., Ichimaru, T., Fujita, I., Tasaki, H., Miyazaki, S. Ulinastatin, an elastase inhibitor, inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease. J. Infect. Dis. 2000, 181,1101-1109.
6. Aibiki, M., Cook, J. A. Ulinastatin, a human trypsin inhibitor, inhibits endotoxin-induced thromboxane B2 production in human monocytes. Crit. Care Med. 1997, 25,430-434.
7. Nakamura, H., Abe, S., Shibata, Y., Sata, M., Kato, S., Saito, H., Hino, T., Takahashi, H., Tomoike, H. Inhibition of neutrophil elastase-induced interleukin-8 gene expression by urinary trypsin inhibitor in human bronchial epithelial cells. Int. Arch. Allergy Immunol. 1997, 112,157-162.
8. Molor-Erdene, P., Okajima, K., Isobe, H., Uchiba, M., Harada, N., Shimozawa, N., Okabe, H. Inhibition of lipopolysaccharideinduced tissue factor expression in monocytes by urinary trypsin inhibitor in vitro and in vivo. Thromb. Haemost. 2005, 94,136-145. (Pubitemid 40974718)
9. Yano, T., Anraku, S., Nakayama, R., Ushijima, K. Neuroprotective effect of urinary trypsin inhibitor against focal cerebral ischemiareperfusion injury in rats. Anesthesiology. 2003, 98,465-473.
10. Tani, T., Aoki, H., Yoshioka, T., Lin, K. J., Kodama, M. Treatment of septic shock with a protease inhibitor in a canine model: A prospective, randomized, controlled trial. Crit. Care Med. 1993, 21,925-930.
11. Molor-Erdene, P., Okajima, K., Isobe, H., Uchiba, M., Harada, N., Okabe, H. Urinary trypsin inhibitor reduces LPS-induced hypotension by suppressing tumor necrosis factor-alpha production through inhibition of Egr-1 expression. Am. J. Physiol. Heart Circ. Physiol. 2005, 288,H1265-1271.
12. Inoue, K., Takano, H., Shimada, A., Yanagisawa, R., Sakurai, M., Yoshino, S., Sato, H., Yoshikawa, T. Urinary trypsin inhibitor protects against systemic inflammation induced by lipopolysaccharide. Mol. Pharmacol. 2005, 67,673-680. (Pubitemid 40365315)
13. Inoue, K., Takano, H., Yanagisawa, R., Sakurai, M., Shimada, A., Sato, H., Kato, Y., Yoshikawa, T. Antioxidative role of urinary trypsin inhibitor in acute lung injury induced by lipopolysaccharide. Int. J. Mol. Med. 2005, 16,1029-1033.
14. Inoue, K., Takano, H., Yanagisawa, R., Sakurai, M., Shimada, A., Yoshino, S., Sato, H., Yoshikawa, T. Protective role of urinary trypsin inhibitor in acute lung injury induced by lipopolysaccharide. Exp. Biol. Med. (Millwood) 2005,230,281-287.
15. Takano, H., Inoue, K., Shimada, A., Sato, H., Yanagisawa, R., Yoshikawa, T. Urinary trypsin inhibitor protects against liver injury and coagulatory disturbances induced by lipopolysaccharide/Dgalactosamine in mice. Lab. Invest. (In Press) .
16. Diaz-Buxo, J. A., Blumenthal, S., Hayes, D., Gores, P., Gordon, B.Galactosamine-induced fulminant hepatic necrosis in unanesthetized canines. Hepatology. 1997, 25,950-957. (Pubitemid 27157140)
17. Kerr, R., Newsome, P., Germain, L., Thomson, E., Dawson, P., Stirling, D., Ludlam, C. A. Effects of acute liver injury on blood coagulation. J. Thromb. Haemost. 2003, 1,754-759.
18. Baudouin, S. V., Howdle, P., O'Grady, J. G., Webster, N. R. Acute lung injury in fulminant hepatic failure following paracetamol poisoning. Thorax. 1995, 50,399-402.
19. Matuschak, G. M., Pinsky, M. R., Klein, E. C., Van Thiel, D.H., Rinaldo, J. E. Effects of D-galactosamine-induced acute liver injury on mortality and pulmonary responses to Escherichia coli lipopolysaccharide. Modulation by arachidonic acid metabolites. Am. Rev. Respir. Dis. 1990, 141,1296-1306.
20. Maehara, K., Kanayama, N., Halim, A., el Maradny, E., Oda, T., Fujita, M., Terao, T. Down-regulation of interleukin-8 gene expression in HL60 cell line by human Kunitz-type trypsin inhibitor. Biochem. Biophys. Res. Commun. 1995, 206,927-934.
21. Aosasa, S., Ono, S., Mochizuki, H., Tsujimoto, C., Ueno, C., Matsumoto, A. Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor alpha production of monocytes. Shock. 2001, 15,101-105.
22. Sauer, A., Hartung, T., Aigner, J., Wendel, A. Endotoxininducible granulocyte-mediated hepatocytotoxicity requires adhesion and serine protease release. J Leukoc Biol 1996, 60,633-643.
23. Chen, G. H., RReddy, R. C., Newstead, M. W., Tateda, K., Kyasapura, B. L., Standiford, T. J. Intrapulmonary TNF gene therapy reverses sepsis-induced suppression of lung antibacterial host defense. J. Immunol. 2000, 165,6496-6503.
24. Torre, D., Minoja, G., Maraggia, D., Chiaranda, M., Tambini, R., Speranza, F., Giola, M. Effect of recombinant IL-1 beta and recombinant gamma interferon on septic acute lung injury in mice. Chest. 1994, 105,1241-1245.
25. Heinzel, F. P. The role of IFN-gamma in the pathology of experimental endotoxemia. J. Immunol. 1990, 45,2920-2924.
26. Kobayashi, H., Suzuki, M., Tanaka, Y., Kanayama, N., Terao, T. A Kunitz-type protease inhibitor, bikunin, inhibits ovarian cancer cell invasion by blocking the calcium-dependent transforming growth factor-beta 1 signaling cascade. J. Biol. Chem. 2003, 278,7790-7799.
27. Koizumi, R., Kanai, H., Maezawa, A., Kanda, T., Nojima, Y., Narusa, T. Therapeutic effects of ulinastatin on experimental crescentic glomerulonephritis in rats. Nephron. 2000, 84,347-353.